Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : LastShadow's Position Trading -- Ignore unavailable to you. Want to Upgrade?

To: Susan Saline who wrote (20833)	8/27/1999 11:48:00 AM
From: AlienTech	Respond to of 43080

Amazing NPLS is down 1 on like 100K! Its weird what companies people buy these days. They want to pay a billion for an outfit like BAMB which any shadow can whip up in a few months for under a mil or pay multi-billions for an outfit like NTOP which basically comes for FREE if you get microsoft netmeeting while not willing to pay 500mil for a company that needs some alien tech's with assets as much as its market cap. heh guess everyone went home already too. Who the hell is going to pay 5 cents for voice that sounds like AT calling home when for the same price you can get pin drop like clarity with your regular phone? sheesh! ONE OF THESE DAYS THERE AINT GONA BE ANYMORE PEOPLE WITH MONEY LEFT TO BUY THESE CRAP!

To: Susan Saline who wrote (20833)	8/27/1999 12:11:00 PM
From: U Up U Down	Read Replies (2) \| Respond to of 43080

Susan, I did nothing with DAB. Still watching it. Here is a hoot, a $105 target on a $3 stock. HIV (used to be CELI?) has a bad history, is this just another chapter? Absolutely no info on Gateway Capital Partners found on Web. ( BW)(GATEWAY-CAPTIAL-PARTNERS) Gateway Capital Partners Announces Investment Opinion on Cel-Sci Corporation Business Editors NOTE TO EDITORS: The following is an investment opinion issued by Gateway Capital Partners LONDON--(BUSINESS WIRE)--Aug. 27, 1999-- Gateway Capital Begins Coverage of Cel-Sci Corporation (HIV) With a STRONG BUY Recommendation and a Price Target of $105 Per Share businesswire.com